Walleye Trading’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,800
Closed -$51 4825
2017
Q1
$51 Buy
1,800
+100
+6% +$2.82K ﹤0.01% 3768
2016
Q4
$50K Buy
+1,700
New +$46.4K ﹤0.01% 3644
2016
Q3
Sell
-1,600
Closed -$30K 5270
2016
Q2
$30K Buy
1,600
+300
+23% +$6.26K ﹤0.01% 4322
2016
Q1
$35K Buy
1,300
+1,000
+333% +$28.7K ﹤0.01% 4121
2015
Q4
$9K Buy
+300
New +$9.63K ﹤0.01% 4777
2015
Q3
Sell
-400
Closed -$16K 5371
2015
Q2
$16K Buy
+400
New +$13.8K ﹤0.01% 4098

Other funds holding PAHC

Walleye Trading's PAHC Position: Q2 2017 in Review

Walleye Trading sold out of Phibro Animal Health (PAHC) in Q2 2017, closing a stake of 1,800 shares — an estimated $51 sold.

Walleye Trading first reported a position in PAHC in Q2 2015 and held it in 6 quarters. The position peaked at $50K in Q4 2016. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2017.

  • Walleye Trading reported no remaining Phibro Animal Health position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 1,800 Phibro Animal Health shares in Q2 2017, an estimated $51.
  • Walleye Trading first reported a position in Phibro Animal Health in Q2 2015 and held it in 6 quarters.
  • Walleye Trading's Phibro Animal Health position peaked at $50K in Q4 2016.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.